Skip to main content
. 2020 Feb 4;10:1753. doi: 10.1038/s41598-020-58666-4

Table 2.

Anticoagulant and /or antiplatelet medication.

Patients Operated lobes
Aspirin®, n (%) 22 (59.5) 34 (58.6)
Plavix®, n (%) 2 (5.4) 3 (5.3)
Marcoumar®, n (%) 7 (18.9) 9 (15.5)
Low-molecular-weight-heparin (LMWH), n (%) 3 (8.1) 6 (10.4)
Aspirin® + Plavix®, n (%) 1 (2.7) 2 (3.4)
Plavix® + LMWH, n (%) 1 (2.7) 2 (3.4)
Marcoumar® + LMWH, n (%) 1 (2.7) 2 (3.4)
Total, n (%) 37 (3.3) 58 (14)